American Journal of Ophthalmology
Volume 150, Issue 3 , Pages 330-337 , September 2010

Analysis of Retinal Flecks in Fundus Flavimaculatus Using High-Definition Spectral-Domain Optical Coherence Tomography

,Accepted 18 April 2010.

References 

  1. Stargardt K. Ueber familiare progressive Degeneration in der Makulagegend des Auges. Albrecht V Graefes Arch Ophthalmol. 1909;71:534–550
  2. Cibis GW, Morey M, Karris DJ. Dominantly inherited macular dystrophy with flecks (Stargardt). Arch Ophthalmol. 1980;98(10):1785
  3. Merin S, Landau J. Abnormal findings in relatives of patients with juvenile hereditary macular degeneration (Stargardt's disease). Ophthalmologica. 1970;161(1):1–10
  4. Franceschetti A, Francois J. Fundus flavimaculatus. Arch Ophthalmol. 1965;25(6):505
  5. Allikmets R, Singh N, Sun H, et al. A photoreceptor cell-specific ATP-binding transporter gene (ABCR) is mutated in recessive Stargardt macular dystrophy. Nat Genet. 1997;15(3):236–246
  6. Cremers FP, van de Pol DJ, van Driel M, et al. Autosomal recessive retinitis pigmentosa and cone-rod dystrophy caused by splice site mutations in the Stargardt's disease gene ABCR. Hum Mol Genet. 1998;7(3):355–362
  7. Rozet JM, Gerber S, Souied E, et al. Spectrum of ABCR gene mutations in autosomal recessive macular dystrophies. Eur J Hum Genet. 1998;6(3):291–295
  8. Cideciyan AV, Aleman TS, Swider M, et al. Mutations in ABCA4 result in accumulation of lipofuscin before slowing of the retinoid cycle: a reappraisal of the human disease sequence. Hum Mol Genet. 2004;13(5):525–534
  9. Aaberg TM. Stargardt's disease and fundus flavimaculatus: evaluation of morphologic progression and intrafamilial co-existence. Trans Am Ophtalmol Soc. 1986;84:453–487
  10. Lois N, Holder GE, Bunce C, Fitzke FW, Bird AC. Phenotypic subtypes of Stargardt macular dystrophy-fundus flavimaculatus. Arch Ophthalmol. 2001;119(3):359–369
  11. Rotenstreich Y, Fishman GA, Anderson RJ. Visual acuity loss and clinical observations in a large series of patients with Stargardt disease. Ophthalmology. 2003;110(6):1151–1158
  12. Gerth C, Andrassi-Darida M, Bock M, Preising MN, Weber BH, Lorenz B. Phenotypes of 16 Stargardt macular dystrophy/fundus flavimaculatus patients with known ABCA4 mutations and evaluation of genotype-phenotype correlation. Graefes Arch Clin Exp Ophthalmol. 2002;240(8):628–638
  13. Klevering BJ, van Driel M, van de Pol DJ, Pinckers AJ, Cremers FP, Hoyng CB. Phenotypic variations in a family with retinal dystrophy as result of different mutations in the ABCR gene. Br J Ophthalmol. 1999;83(8):914–918
  14. Holz FG. Autofluorescence imaging of the macula. Ophthalmologe. 2001;98(1):10–18
  15. Von Ruckmann A, Fitzke FW, Bird AC. In vivo autofluorescence in macular dystrophies. Arch Ophthalmol. 1997;115(5):609–615
  16. Souied E, Kaplan J, Coscas G, et al. Macular dystrophies. J Fr Ophtalmol. 2003;26(7):743–762
  17. Querques G, Leveziel N, Benhamou N, Voigt M, Soubrane G, Souied EH. Analysis of retinal flecks in fundus flavimaculatus using optical coherence tomography. Br J Ophthalmol. 2006;90(9):1157–1162
  18. Zawadzki R, Jones S, Olivier S, et al. Adaptive-optics optical coherence tomography for high-resolution and high-speed 3D retinal in-vivo imaging. Opt Express. 2005;13:8532–8546
  19. Pircher M, Gotzinger E, Findl O, et al. Human macula investigated in vivo with polarization-sensitive optical coherence tomography. Invest Ophthalmol Vis Sci. 2006;47(12):5487–5494
  20. Drexler W. Cellular and functional optical coherence tomography of the human retina: the Cogan lecture 1. Invest Ophthalmol Vis Sci. 2007;48(12):5339–5351
  21. Michels S, Pircher M, Geitzenauer W, et al. Value of polarization sensitive optical coherence tomography in diseases affecting the retinal pigment epithelium. Br J Ophthalmol. 2008;92(2):204–209
  22. Fleckenstein M, Charbel Issa P, Helb HM, et al. High-resolution spectral domain-OCT imaging in geographic atrophy associated with age-related macular degeneration. Invest Ophthalmol Vis Sci. 2008;49(9):4137–4144
  23. Gerth C, Zawadzki RJ, Choi SS, Keltner JL, Park SS, Werner JS. Visualization of lipofuscin accumulation in Stargardt macular dystrophy by high-resolution Fourier-domain optical coherence tomography. Arch Ophthalmol. 2007;125(4):575
  24. Bellmann C, Holz FG, Schapp O, et al. Topography of fundus antofluorescence with a new confocal scanning laser ophthalmoscope. Ophthalmologe. 1997;94(6):385–391
  25. Ergun E, Hermann B, Wirtitsch M, et al. Assessment of central visual function in Stargardt's disease/fundus flavimaculatus with ultrahigh-resolution optical coherence tomography. Invest Ophthalmol Vis Sci. 2005;46(1):310–316
  26. Querques G, Prato R, Iaculli C, et al. Correlation of visual function impairment and OCT findings in patients with Stargardt disease and fundus flavimaculatus. Eur J Ophthalmol. 2008;18(2):239–247
  27. Gomes NL, Greenstein VC, Carlson JN, et al. A comparison of fundus autofluorescence and retinal structure in patients with Stargardt disease. Invest Ophthalmol Vis Sci. 2009;50(8):3953–3959

PII: S0002-9394(10)00257-6

doi: 10.1016/j.ajo.2010.04.001

American Journal of Ophthalmology
Volume 150, Issue 3 , Pages 330-337 , September 2010

Article Tools

* Image Usage & Resolution